These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12054544)

  • 1. Butyrate reduces colonic paracellular permeability by enhancing PPARgamma activation.
    Kinoshita M; Suzuki Y; Saito Y
    Biochem Biophys Res Commun; 2002 May; 293(2):827-31. PubMed ID: 12054544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of PPARgamma is not involved in butyrate-induced epithelial cell differentiation.
    Ulrich S; Wächtershäuser A; Loitsch S; von Knethen A; Brüne B; Stein J
    Exp Cell Res; 2005 Oct; 310(1):196-204. PubMed ID: 16112107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes induce peroxisome proliferator-activated receptor gamma-mediated growth inhibition, transactivation, and differentiation markers in colon cancer cells.
    Chintharlapalli S; Smith R; Samudio I; Zhang W; Safe S
    Cancer Res; 2004 Sep; 64(17):5994-6001. PubMed ID: 15342379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
    Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
    Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
    Han S; Inoue H; Flowers LC; Sidell N
    Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARgamma ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21 pathway.
    Han C; Demetris AJ; Michalopoulos GK; Zhan Q; Shelhamer JH; Wu T
    Hepatology; 2003 Jul; 38(1):167-77. PubMed ID: 12829999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor gamma ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia.
    Zang C; Liu H; Posch MG; Waechter M; Facklam M; Fenner MH; Ruthardt M; Possinger K; Phillip Koeffler H; Elstner E
    Leuk Res; 2004 Apr; 28(4):387-97. PubMed ID: 15109539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor-alpha inhibits peroxisome proliferator-activated receptor gamma activity at a posttranslational level in hepatic stellate cells.
    Sung CK; She H; Xiong S; Tsukamoto H
    Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G722-9. PubMed ID: 14656714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of PPAR gamma in colon tumor cell lines by oxidized metabolites of linoleic acid, endogenous ligands for PPAR gamma.
    Bull AW; Steffensen KR; Leers J; Rafter JJ
    Carcinogenesis; 2003 Nov; 24(11):1717-22. PubMed ID: 12949056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary culture model of peroxisome proliferator-activated receptor gamma activity in prostate cancer cells.
    Xu Y; Iyengar S; Roberts RL; Shappell SB; Peehl DM
    J Cell Physiol; 2003 Jul; 196(1):131-43. PubMed ID: 12767049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a functional peroxisome proliferator activated receptor response element in the 3' untranslated region of the human bcl-2 gene.
    Butts BD; Tran NL; Briehl MM
    Int J Oncol; 2004 May; 24(5):1305-10. PubMed ID: 15067355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of polyamine catabolism by activated Ki-ras in human colon cancer cells.
    Ignatenko NA; Babbar N; Mehta D; Casero RA; Gerner EW
    Mol Carcinog; 2004 Feb; 39(2):91-102. PubMed ID: 14750214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARbeta activity.
    Sumanasekera WK; Tien ES; Davis JW; Turpey R; Perdew GH; Vanden Heuvel JP
    Biochemistry; 2003 Sep; 42(36):10726-35. PubMed ID: 12962497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of thalidomide on non-small cell lung cancer (NSCLC) cell lines: possible involvement in the PPARgamma pathway.
    DeCicco KL; Tanaka T; Andreola F; De Luca LM
    Carcinogenesis; 2004 Oct; 25(10):1805-12. PubMed ID: 15205358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of peroxisome proliferator activated receptor gamma in cftr-/- mice.
    Ollero M; Junaidi O; Zaman MM; Tzameli I; Ferrando AA; Andersson C; Blanco PG; Bialecki E; Freedman SD
    J Cell Physiol; 2004 Aug; 200(2):235-44. PubMed ID: 15174093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of peroxisome proliferator-activated receptor gamma does not explain the antiproliferative activity of the nonsteroidal anti-inflammatory drug indomethacin on human colorectal cancer cells.
    Hawcroft G; Gardner SH; Hull MA
    J Pharmacol Exp Ther; 2003 May; 305(2):632-7. PubMed ID: 12606626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice.
    Osawa E; Nakajima A; Wada K; Ishimine S; Fujisawa N; Kawamori T; Matsuhashi N; Kadowaki T; Ochiai M; Sekihara H; Nakagama H
    Gastroenterology; 2003 Feb; 124(2):361-7. PubMed ID: 12557142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of PPARgamma is reduced by medium supplementation with L-glutamine in human colorectal Caco-2 cells.
    Fiatte C; Huin C; Collet P; Plénat F; Dauça M; Schohn H
    Int J Mol Med; 2008 Dec; 22(6):825-32. PubMed ID: 19020782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of specific luminal factors on the colonic epithelium: high-dose butyrate and physical changes suppress early carcinogenic events in rats.
    Wong CS; Sengupta S; Tjandra JJ; Gibson PR
    Dis Colon Rectum; 2005 Mar; 48(3):549-59. PubMed ID: 15711862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced production of IL-18 in butyrate-treated intestinal epithelium by stimulation of the proximal promoter region.
    Kalina U; Koyama N; Hosoda T; Nuernberger H; Sato K; Hoelzer D; Herweck F; Manigold T; Singer MV; Rossol S; Böcker U
    Eur J Immunol; 2002 Sep; 32(9):2635-43. PubMed ID: 12207348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.